BrainsWay Ltd. (BWAY) on Decifer

Decifer ranks BWAY number 112 of 276 tracked names on durable business quality.

Why it ranks here

• Its returns on invested money are modest, around 5% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 27% a year and profits grew 365% over the past year.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares.
• Its profit margin and growth are both unusually high right now compared to its own history, the kind of combination that often fades once conditions normalize.
• Profits grew 365% and revenue about 27% but returns are modest around 5% and this margin and growth pop tends to normalize, with no worldview role to anchor it.

The current read

The evidence on BWAY lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: BrainsWay Ltd. operates in medical - devices. That places it inside the Healthcare, Biotech & Devices story.

Read the full BWAY research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.